Citadel Advisors - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is and the CUSIP is 09627Y959. A total of 1 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2015$134,000
+91.4%
5,100
+54.5%
0.00%
Q3 2015$70,0003,3000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 103,900$5,217,8580.02%
JANE STREET GROUP, LLC 147,200$7,392,3840.00%
SIMPLEX TRADING, LLC 38,600$1,9380.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders